Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
AVDL on Nasdaq
Mark Anthony McCamish - trading volume in the past year for Avadel Pharmaceuticals Plc
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
ADSs |
67K |
$972K |
$14.50 |
Dec 28, 2023 |
By Matthew 5 LLC |
|
|
Ordinary Shares |
67K |
|
|
Jul 30, 2024 |
By Matthew 5 LLC |
|
|
Ordinary Shares |
11K |
|
|
Jul 30, 2024 |
Direct |
|
|
Stock Option (Right to Buy) |
11K |
|
|
Jul 30, 2024 |
Direct |
Ordinary Shares |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.